l-Arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease

Atherosclerosis

Volumn 204, Issue 1, 2009, Pages 73-78

  Settergren, M ^a   Bohm F ^a,b   Malmstrom R E ^a   Channon, K M ^b   Pernow, J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ischemia reperfusion injury; l Arginine; Tetrahydrobiopterin; Type 2 diabetes

Indexed keywords

ACETYLCHOLINE; ARGININE; BIOPTERIN; DIHYDROBIOPTERIN; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE; TETRAHYDROBIOPTERIN;

AGED; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DIABETIC PATIENT; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEASUREMENT; FOREARM BLOOD FLOW; HEART PROTECTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SINGLE BLIND PROCEDURE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

AGED; ARGININE; BIOPTERIN; BLOOD FLOW VELOCITY; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; REGIONAL BLOOD FLOW; REPERFUSION INJURY; TREATMENT OUTCOME; VASODILATION; VASODILATOR AGENTS;

EID: 67349092191     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.08.034     Document Type: Article

References (34)

1. Ambrosio G., and Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 138 (1999) S69-75
2. Lefer A.M., and Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32 (1996) 743-751
3. Weyrich A.S., Ma X.L., and Lefer A.M. The role of l-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86 (1992) 279-288
4. Tiefenbacher C.P., Chilian W.M., Mitchell M., and DeFily D.V. Restoration of endothelium-dependent vasodilation after reperfusion injury by tetrahydrobiopterin. Circulation 94 (1996) 1423-1429
5. Luscher T.F., and Noll G. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis 118 Suppl (1995) S81-90
6. Guzik T.J., Mussa S., Gastaldi D., et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105 (2002) 1656-1662
7. Pieper G.M. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31 (1998) 1047-1060
8. Pannirselvam M., Verma S., Anderson T.J., and Triggle C.R. Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 136 (2002) 255-263
9. Vasquez-Vivar J., Martasek P., Whitsett J., Joseph J., and Kalyanaraman B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J 362 (2002) 733-739
10. Schmidt T.S., and Alp N.J. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond) 113 (2007) 47-63
11. 4. Proc Natl Acad Sci USA 104 (2007) 15081-15086
12. Heitzer T., Krohn K., Albers S., and Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 43 (2000) 1435-1438
13. Mayahi L., Heales S., Owen D., et al. (6R)-5,6,7,8-Tetrahydro-l-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm. Arterioscler Thromb Vasc Biol 27 (2007) 1334-1339
14. Pernow J., Bohm F., Beltran E., and Gonon A. l-Arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo. J Appl Physiol 95 (2003) 2218-2222
15. Miettinen H., Lehto S., Salomaa V., et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21 (1998) 69-75
16. Lefer D.J., Scalia R., Jones S.P., et al. HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB J 15 (2001) 1454-1456
17. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
18. Wilkinson I.B., and Webb D.J. Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol 52 (2001) 631-646
19. Bohm F., Ahlborg G., and Pernow J. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Clin Sci (Lond) 102 (2002) 321-327
20. Schrage W.G., Dietz N.M., Eisenach J.H., and Joyner M.J. Agonist-dependent variability of contributions of nitric oxide and prostaglandins in human skeletal muscle. J Appl Physiol 98 (2005) 1251-1257
21. Heales S., and Hyland K. Determination of quinonoid dihydrobiopterin by high-performance liquid chromatography and electrochemical detection. J Chromatogr 494 (1989) 77-85
22. Thum T., Fraccarollo D., Schultheiss M., et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56 (2007) 666-674
23. Imaizumi T., Hirooka Y., Masaki H., et al. Effects of l-arginine on forearm vessels and responses to acetylcholine. Hypertension 20 (1992) 511-517
24. Closs E.I., Scheld J.S., Sharafi M., and Forstermann U. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol 57 (2000) 68-74
25. Wu G., and Meininger C.J. Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat. Am J Physiol 269 (1995) H1312-1318
26. Bivalacqua T.J., Hellstrom W.J., Kadowitz P.J., and Champion H.C. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 283 (2001) 923-927
27. Hein T.W., Zhang C., Wang W., Chang C.I., Thengchaisri N., and Kuo L. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J 17 (2003) 2328-2330
28. Werner-Felmayer G., Werner E.R., Fuchs D., et al. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem 268 (1993) 1842-1846
29. Milstien S., and Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263 (1999) 681-684
30. Katusic Z.S. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?. Am J Physiol Heart Circ Physiol 281 (2001) H981-H986
31. Wilson A.M., Harada R., Nair N., Balasubramanian N., and Cooke J.P. l-Arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation 116 (2007) 188-195
32. Mahaffey K.W., Puma J.A., Barbagelata N.A., et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol 34 (1999) 1711-1720
33. Avkiran M., and Marber M.S. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol 39 (2002) 747-753
34. Bohm F., Settergren M., Gonon A.T., and Pernow J. The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans. Clin Sci (Lond) 108 (2005) 357-363